INKlings

 

 

spacer
NIH announces processes to enable stem cell research

The NIH Office of Extramural Research has announced that it is initiating a process to enable researchers to use federal funds to conduct research using human embryonic stem cells that existed as of Aug. 9 and that meet the criteria established by President Bush.

The NIH emphasized that investigators may not conduct research on any human embryonic stem cells until it issues the policies and procedures that will enable researchers and their institutions to document adherence to criteria established by the president for use of these cells with federal funds(direct and F&A). NIH has issued an update on existing human embryonic stem cells information website.

In order to facilitate research using human embryonic stem cells, NIH is developing a Web-based Human Embryonic Stem Cell Registry, that will list the human embryonic stem cells that meet the eligibility criteria. The Registry will be accessible on the NIH Home Page.

Initially, the Registry will contain basic information about the cells. This information will include a unique identifier; the name of the company or laboratory that derived the cells; contact information for the company/laboratory; and an assurance that the cells meet the President's criteria. In the future, to further assist researchers, additional information may also be included in the Registry, such as details about the derivation of the cells, the number of passages, culture conditions, and growth characteristics; a description of efforts to characterize the cells; DNA fingerprinting data; and quality assurance data.

General questions or comments about the Registry should be addressed to stemcellregistry@od.nih.gov. Researchers who are interested in studying or using particular human embryonic stem cells in their research will be expected to contact the company/laboratory directly to arrange for access to these cells.

Source: NIH Guide, August 31, 2001


spacer

<<back

 

bar


E-Mail this Page to:




about us | current issue | archive | home
E-mail us.